Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
Novel immunisation methods against respiratory syncytial virus (RSV) are emerging, but knowledge of risk factors for severe RSV disease is insufficient for optimal targeting of interventions against them.
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants
Infants younger than 6 months are at risk of severe SARS-CoV-2 infection.
High number of HPAI H5 virus infections and antibodies in wild carnivores in the Netherlands, 2020–2022
Wild birds, particularly those belonging to the orders Anseriformes and Charadriiformes, are the natural host of a wide range of low pathogenicity avian influenza (LPAI) viruses.
A Fragile State of Preparedness: 2023 Report on the State of the World's Preparedness
The Global Preparedness Monitoring Board (GPMB) 2023 Report points out that global preparedness for pandemics and other disease outbreaks remains inadequate, making four key recommendations to urgently strengthen global preparedness.
The European Respiratory Virus Surveillance Summary (ERVISS)
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and severe acute respiratory syndrome coronavirus 2 for the EU/EEA and the WHO European Region
How the current bird flu strain evolved to be so deadly
Genetic changes to avian influenza viruses have led to spread among many wild species, creating an uncontrollable global outbreak.
The episodic resurgence of highly pathogenic avian influenza H5 virus
Highly pathogenic avian influenza (HPAI) H5N1 activity has intensified globally since 2021, increasingly causing mass mortality in wild birds and poultry and incidental infections in mammals.
EU Countries miss flu vaccination target (except for one)
European health ministers agreed on a target of vaccinating 75% of older people in 2009 ‒ almost all countries are still falling short.
Why Vaccinate Healthy 2- to 17-Year-Olds Against Influenza?
On February 2023, the French National Authority for Health (HAS) recommended extending flu shots to children aged 2-17 years without comorbidities.
Serotonin reduction in post-acute sequelae of viral infection
Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and impairs hippocampal responses and memory. These findings provide a possible explanation for neurocognitive symptoms associated with viral persistence in Long COVID.
SARS-CoV-2 evolution in the Omicron era
Since SARS-CoV-2 BA.5 (Omicron) emerged and spread in 2022, Omicron lineages have markedly diversified.
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
In the last three years, extensive research has demonstrated the safety and efficacy of COVID-19 vaccines. These vaccines have played a critical role in reducing mortality and hospitalization rates.